PMC3364107_01
CT scan.
ccrep-5-2012-069f1.jpg
PMC3364107_01_ccrep-5-2012-069f1.jpg
f1-ccrep-5-2012-069
Neither abdominal nor pelvic pathological lymph nodes, nor bone lesions were observed (Fig. 1).
PET-TC scan.
ccrep-5-2012-069f2.jpg
PMC3364107_01_ccrep-5-2012-069f2.jpg
f2-ccrep-5-2012-069
Hematoxylin-eosin 10x and 20x.
ccrep-5-2012-069f3.jpg
PMC3364107_01_ccrep-5-2012-069f3.jpg
f3-ccrep-5-2012-069
These characteristics allow the classification of the lesion as a neuroendocrine tumor with histological and immunostaining characteristics compatible with prostatic paraganglioma (Figs. 3 and 4).
Inmunostaining (Vimentin, Synaptophysin, S100 10x).
ccrep-5-2012-069f4.jpg
PMC3364107_01_ccrep-5-2012-069f4.jpg
f4-ccrep-5-2012-069
These characteristics allow the classification of the lesion as a neuroendocrine tumor with histological and immunostaining characteristics compatible with prostatic paraganglioma (Figs. 3 and 4).